Protein microarray technology

MF Templin, D Stoll, M Schrenk, PC Traub… - TRENDS in …, 2002 - cell.com
Microarray technology allows the simultaneous analysis of thousands of parameters within a
single experiment. Microspots of capture molecules are immobilized in rows and columns …

Antibody engineering

J Maynard, G Georgiou - Annual review of biomedical …, 2000 - annualreviews.org
▪ Abstract Antibodies are unique in their high affinity and specificity for a binding partner, a
quality that has made them one of the most useful molecules for biotechnology and …

Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen

Y Chen, C Wiesmann, G Fuh, B Li… - Journal of molecular …, 1999 - Elsevier
The Fab portion of a humanized antibody (Fab-12; IgG form known as rhuMAb VEGF) to
vascular endothelial growth factor (VEGF) has been affinity-matured through …

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

DR Burton, J Pyati, R Koduri, SJ Sharp, GB Thornton… - Science, 1994 - science.org
The ability of antibodies to neutralize diverse primary isolates of human immunodeficiency
virus-type 1 in vitro has been questioned, with implications for the likely efficacy of vaccines …

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range

WP Yang, K Green, S Pinz-Sweeney, AT Briones… - Journal of molecular …, 1995 - Elsevier
We describe the investigation of methodologies for the creation of very high affinity human
antibodies. The high affinity human antibody b4/12 was optimized for its affinity to the human …

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

R Schier, A McCall, GP Adams, KW Marshall… - Journal of molecular …, 1996 - Elsevier
We determined the extent to which additional binding energy could be achieved by
diversifying the complementarity determining regions (CDRs) located in the center of the …

Human antibodies for viral infections

JE Crowe Jr - Annual review of immunology, 2022 - annualreviews.org
Antibodies have been used to prevent or treat viral infections since the nineteenth century,
but the full potential to use passive immunization for infectious diseases has yet to be …

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human …

P Roben, JP Moore, M Thali, J Sodroski… - Journal of …, 1994 - Am Soc Microbiol
Six recombinant human Fab fragments that were derived from the same human
immunodeficiency virus type 1 (HIV-1)-infected individual and are directed against the CD4 …

Synthetic antibody phage libraries

G Fuh, SS Sidhu - US Patent 7,985,840, 2011 - Google Patents
US7985840B2 - Synthetic antibody phage libraries - Google Patents US7985840B2 -
Synthetic antibody phage libraries - Google Patents Synthetic antibody phage libraries …

Strategies for selection of antibodies by phage display

AD Griffiths, AR Duncan - Current opinion in biotechnology, 1998 - Elsevier
Phage antibody-display is rapidly maturing into a very effective tool for antibody generation.
The recent development of large primary antibody libraries enables selection of antibodies …